Zydus Cadila which is developing DNA vaccines has concluded its clinical trial for between the age group of 12 to 18 years of age and subject to the statutory permission, the same may be available in near future for children of the age group of 12 to 18 years of age.
The Centre, in the affidavit filed through standing counsel Anurag Ahluwalia, said vaccination is the top most priority of the government and all efforts are being made to achieve an objective of 100 per cent vaccination in the shortest time possible keeping the available resources in mind and availability of vaccine doses into consideration.
It said from May 1, onwards under the new liberalised pricing and accelerated national COVID vaccination strategy, all citizens above